Serologic determinants of survival in patients with squamous cell carcinoma of the head and neck
- 31 October 1990
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 160 (4) , 434-438
- https://doi.org/10.1016/s0002-9610(05)80560-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Circulating immune complexes and chemotherapy response in patients with head and neck cancerHead & Neck, 1989
- Prognostic value of serial determinations of circulating immune complex levels in malignant melanomaCancer Immunology, Immunotherapy, 1988
- THE RELATIONSHIP OF CIRCULATING IgA TO CELLULAR IMMUNITY IN HEAD AND NECK CANCER PATIENTSThe Laryngoscope, 1988
- Serum Immunoglobulin Levels in Patients with Head and Neck Cancer (IgE, IgA, IgM, IgG)Oncology, 1986
- Suppression of polyclonal human B cell activation by IgG binding factors: Interference with the maturation of Ig-containing cells into Ig-secreting cellsCellular Immunology, 1984
- Modulation of Fc receptors of mononuclear phagocytes by immobilized antigen-antibody complexes. Quantitative analysis of the relationship between ligand number and Fc receptor response.The Journal of Experimental Medicine, 1983
- Effect of sera from patients with rheumatoid arthritis on normal lymphocytes: a possible immunoregulatory role for immune complexes.Annals of the Rheumatic Diseases, 1982
- Natural cytotoxicity in rheumatoid arthritis and systemic lupus erythematosusClinical Immunology and Immunopathology, 1981
- Serum glycoproteins and immunoglobulins in nasopharyngeal carcinomaThe American Journal of Surgery, 1979
- Quantitative change of serum protein and immunoglobulin in patients with solid cancersJournal of Surgical Oncology, 1977